MD vs. CHE
Compare and contrast key facts about MEDNAX, Inc. (MD) and Chemed Corporation (CHE).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: MD or CHE.
Correlation
The correlation between MD and CHE is 0.45, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
MD vs. CHE - Performance Comparison
Loading data...
Key characteristics
MD:
1.42
CHE:
-0.01
MD:
2.18
CHE:
0.09
MD:
1.25
CHE:
1.01
MD:
0.64
CHE:
-0.07
MD:
4.62
CHE:
-0.20
MD:
13.10%
CHE:
7.02%
MD:
55.53%
CHE:
24.51%
MD:
-93.99%
CHE:
-56.47%
MD:
-87.10%
CHE:
-12.07%
Fundamentals
MD:
$1.25B
CHE:
$8.34B
MD:
-$1.00
CHE:
$20.49
MD:
0.88
CHE:
2.25
MD:
0.63
CHE:
3.35
MD:
1.57
CHE:
7.04
MD:
$1.98B
CHE:
$2.49B
MD:
$453.32M
CHE:
$834.93M
MD:
-$57.10M
CHE:
$452.20M
Returns By Period
In the year-to-date period, MD achieves a 10.75% return, which is significantly higher than CHE's 7.73% return. Over the past 10 years, MD has underperformed CHE with an annualized return of -14.54%, while CHE has yielded a comparatively higher 17.33% annualized return.
MD
10.75%
7.15%
-7.80%
76.76%
0.58%
-14.54%
CHE
7.73%
-3.42%
2.33%
-0.53%
5.78%
17.33%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
MD vs. CHE — Risk-Adjusted Performance Rank
MD
CHE
MD vs. CHE - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for MEDNAX, Inc. (MD) and Chemed Corporation (CHE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
MD vs. CHE - Dividend Comparison
MD has not paid dividends to shareholders, while CHE's dividend yield for the trailing twelve months is around 0.33%.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
MD MEDNAX, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
CHE Chemed Corporation | 0.33% | 0.34% | 0.27% | 0.29% | 0.26% | 0.25% | 0.28% | 0.41% | 0.44% | 0.62% | 0.61% | 0.79% |
Drawdowns
MD vs. CHE - Drawdown Comparison
The maximum MD drawdown since its inception was -93.99%, which is greater than CHE's maximum drawdown of -56.47%. Use the drawdown chart below to compare losses from any high point for MD and CHE. For additional features, visit the drawdowns tool.
Loading data...
Volatility
MD vs. CHE - Volatility Comparison
MEDNAX, Inc. (MD) has a higher volatility of 15.19% compared to Chemed Corporation (CHE) at 9.52%. This indicates that MD's price experiences larger fluctuations and is considered to be riskier than CHE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
MD vs. CHE - Financials Comparison
This section allows you to compare key financial metrics between MEDNAX, Inc. and Chemed Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
MD vs. CHE - Profitability Comparison
MD - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, MEDNAX, Inc. reported a gross profit of 102.64M and revenue of 458.36M. Therefore, the gross margin over that period was 22.4%.
CHE - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Chemed Corporation reported a gross profit of 200.40M and revenue of 646.94M. Therefore, the gross margin over that period was 31.0%.
MD - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, MEDNAX, Inc. reported an operating income of 38.71M and revenue of 458.36M, resulting in an operating margin of 8.4%.
CHE - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Chemed Corporation reported an operating income of 94.76M and revenue of 646.94M, resulting in an operating margin of 14.7%.
MD - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, MEDNAX, Inc. reported a net income of 20.74M and revenue of 458.36M, resulting in a net margin of 4.5%.
CHE - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Chemed Corporation reported a net income of 71.76M and revenue of 646.94M, resulting in a net margin of 11.1%.